Detalles de la búsqueda
1.
A dose-dense short-term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the "CARMEN" phase II trial.
Br J Haematol
; 192(1): 119-128, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33085777
2.
Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era.
Br J Haematol
; 168(5): 654-62, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25312994
3.
[The primary mediastinal lymphoma: state of the art and therapeutical perspectives]. / Il linfoma primitivo del mediastino: stato dell'arte e prospettive terapeutiche.
Recenti Prog Med
; 104(5): 203-8, 2013 May.
Artículo
en Italiano
| MEDLINE | ID: mdl-23748685
4.
Platelet activation state in early stages of COVID-19.
Minerva Anestesiol
; 88(6): 472-478, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35315619
5.
Safety and activity of a new intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt lymphoma.
Br J Haematol
; 159(2): 252-5, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22924636
6.
Assessing "occult" cervical cord damage in patients with neuropsychiatric systemic lupus erythematosus using diffusion tensor MRI.
J Neurol Neurosurg Psychiatry
; 78(8): 893-5, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17371904
7.
High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial.
J Clin Oncol
; 33(33): 3903-10, 2015 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26282634
8.
Phase I study of NGR-hTNF, a selective vascular targeting agent, in combination with cisplatin in refractory solid tumors.
Clin Cancer Res
; 17(7): 1964-72, 2011 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21307147
9.
Defining the optimal biological dose of NGR-hTNF, a selective vascular targeting agent, in advanced solid tumours.
Eur J Cancer
; 46(1): 198-206, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19900802
Resultados
1 -
9
de 9
1
Próxima >
>>